| Literature DB >> 30463184 |
Wenlong Wei1,2, Xia Wang3, Jinjun Hou4, Changliang Yao5, Zijin Feng6, Jianqing Zhang7, Sumei Han8, Yanping Deng9, Yong Huang10, Wanying Wu11, Dean Guo12.
Abstract
The mass spectrometry (MS) has been widely used for profiling chemical components of traditional Chinese medicine (TCM). However, there are few studies reporting quality control of TCM based on mass spectrometry fingerprint (MSF) due to its complicated operation and high cost. The aim of this study was to extend the application of MSF for quality evaluation of TCM. In this study, an MSF based on single quadrupole mass spectrometry method was established, and was successfully used for the quality control of Venenum bufonis (VB), a famous TCM which was used clinically for cancer treatment in China. The results showed that the superiority of MSF for more chemical information exposure and the finding of more potential chemical markers (eight versus four) compared with the traditional photo-diode array (a kind of ultra violet detector, PDA). Besides, the performance of MSF was also validated by similarity and principle component analysis (PCA) of MS data acquired on two other mass spectrometry (low-resolution, triple quadrupole, QQQ, and high-resolution, quadruple time-of-flight, Q-TOF), showing high consistency with QQQ and Q-TOF, but robustness with few parameters' settings. Based on our study, MSF could be widely applied for the quality control of TCM.Entities:
Keywords: Venenum bufonis; chemometrics analysis; mass spectrometry fingerprint; quality control
Mesh:
Substances:
Year: 2018 PMID: 30463184 PMCID: PMC6278474 DOI: 10.3390/molecules23113020
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1A general workflow for implementation of a compact single quadrupole mass spectrometer for fingerprint analysis: Venenum bufonis as a case study.
Figure 2Fingerprints of 28 batches of VB based on PDA (a) and QDA (b).
Figure 3Common peaks based on PDA based fingerprint (a) and MSF (b).
Characterization of chemical compounds by UPLC-QDA and UPLC-Q-TOF/MS from VB.
| NO. | Tr (min) | QDa ( | Q-TOF ( | Product Ion | Q-TOF (ppm) | Formula [M + H]+ | Identification |
|---|---|---|---|---|---|---|---|
|
| |||||||
|
| 1.65 | 275 | 275.1357 | 257.1235 | 0.7 | C10H19N4O5 | Unknown |
|
| 3.07 | 303 | 303.1671 | 250.1181 | 1 | C12H23N4O5 | Unknown |
|
| 3.37 | 219 | 219.1497 | 160.08 | −0.5 | C13H19N2O | Bufotenidine |
|
| 3.5 | 347 | 347.1931 | 294.4285; 219.1490 | −0.2 | C14H27N4O6 | Unknown |
|
| 3.81 | 317 | 317.1825 | 158.09; 175.12; 264.14 | 2.2 | C13H25N4O5 | Pimeloyl arginine |
|
| 3.94 | 203 | 203.1144 | 173.0709; 118.0649 | 3.8 | C7H15N4O3 | Unknown |
|
| 4.3 | 326 | 326.1716 | 124.0865 | −2.5 | C15H24N3O5 | Unknown |
|
| 4.42 | 331 | 331.1981 | 278.15; 158.09; 250.16 | 1.2 | C14H27N4O5 | Suberoyl arginine |
|
| 4.65 | 345 | 345.2138 | 159.0663 | 3.5 | C15H29N4O5 | Unknown |
|
| 4.87 | 359 | 359.2294 | 241.0692; 116.0694 | −2.5 | C16H31N4O5 | Unknown |
|
| 5.13 | 345 | 345.2138 | 302.0553; 112.0870 | 0.8 | C15H29N4O5 | Unknown |
|
| 6.61 | 575 | 575.3121 | 352.1914; 241.0693 | 0.5 | C34H43N2O6 | Unknown |
|
| 11.33 | 643 | 643.3694 | 337.1077; 275.1344 | −1.3 | C34H51N4O8 | Unknown |
|
| 13.1 | 715 | 715.4281 | 421.1974; 331.1978 | −0.1 | C38H59N4O9 | Unknown |
|
| 17.97 | 699 | 699.4349 | 536.6514; 150.9849 | 0.3 | C39H55N8O4 | Unknown |
|
| |||||||
|
| 7.02 | 417 | 417.2208 | 399.2163 | 0.3 | C24H33O6 | Iso-arenobufagin |
|
| 7.33 | 417 | 417.2271 | 399.2173 | −0.6 | C24H33O6 | Iso-arenobufagin |
|
| 8.27 | 417 | 417.2280 | 399.22; 363.19; 335.20 | 0.3 | C24H33O6 | Arenobufagin |
|
| 8.68 | 417 | 417.2274 | 363.19; 335.20 | −0.3 | C24H33O6 | Hellebrigenin |
|
| 8.91 | 417 | 417.2268 | 363.19; 335.20 | −0.9 | C24H33O6 | Iso-hellebrigenin/arenobufagin |
|
| 9.07 | 403 | 403.2483 | 385.24; 367.23; 349.22; 271.21 | −0.1 | C24H35O5 | Iso-telocinobufagin |
|
| 9.33 | 459 | 459.2386 | 363.1957; 301.1436 | 0.3 | C26H35O7 | Hydroxycinobufagin |
|
| 9.82 | 415 | 415.2215 | 337.1052; 317.1823 | −0.6 | C24H31O6 | Unknown |
|
| 10.12 | 403 | 403.2484 | 331.1976; 301.1424 | 0.0 | C24H35O5 | Unknown |
|
| 10.27 | 473 | 473.2164 | 367.1902; 349.1817 | -1.1 | C26H33O8 | Iso-19-oxocinobufotalin |
|
| 10.99 | 401 | 401.2317 | 347.1964; 301.1416 | -1.1 | C24H33O5 | Iso-desacetylcinobufagin |
|
| 12.08 | 403 | 403.2484 | 385.24; 367.23; 349.22; 271.21 | 0.1 | C24H35O5 | Telocinobufagin |
|
| 12.65 | 445 | 445.2597 | 385.24; 367.23; 349.22; 331.21 | 0.7 | C26H37O6 | Bufotalin |
|
| 13.00 | 399 | 399.2168 | 331.1969 | -0.3 | C24H31O5 | Unknown |
|
| 13.40 | 457 | 457.2226 | 397.2018; 333.1857 | 0.0 | C26H33O7 | Iso-19-oxocinobufagin |
|
| 13.72 | 401 | 401.2322 | 365.2052; 337.1026 | -0.6 | C24H33O5 | Iso-marinobufagin |
|
| 13.89 | 459 | 459.2383 | 381.21; 363.20; 345.18 | 0.5 | C26H35O7 | Cinobufatalin |
|
| 15.75 | 387 | 387.2535 | 351.23; 333.22; 255.21 | -0.2 | C24H35O4 | Bufalin |
|
| 19.14 | 385 | 385.2368 | 367.23; 321.22;271.20; 253.20 | -1.1 | C24H33O4 | Resibufogenin |
|
| 19.47 | 443 | 443.2434 | 365.21; 347.20; 329.19 | 0.2 | C26H35O6 | Cinobufagin |
Figure 4Similarities analysis of data acquired on four different detectors.
Figure 5PCA analysis of data acquired on four different detectors (a–d) represents results based on PDA, QDA, QQQ, and Q-TOF, respectively).
Figure 6OPLS-DA analysis of 28 batches of VB samples based on PDA and QDA detectors. (a) The score scatter plot of PDA, (b) the score scatter plot of QDA, (c) the VIP pot of PDA, (d) the VIP pot of QDA, (e) the S-plot of PDA, and (f) the VIP pot of QDA.